Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Download PDF
May 3, 2016
/
News
Share
the Post
Related
Posts
Hepatitis C vaccine fails to prevent chronic infections
18 hospitals offer free DAA therapy for treatment of Hepatitis C in Malaysia
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015
Read More
Story from Ayu Oktariani, Bandung, Indonesia
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
Letter from Community in Asia and Eastern Europe to Global Fund Board for Financing Hep C Treatment
The Updated Pricing of Ledipasvir and Sofosbuvir Co-formulated tablets
2018 IAS Brief Document Ending an Epidemic – Prioritizing People Who Inject Drugs in HCV elimination Efforts.
